This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).
McNeil, S. Correspondence to the editor. Nat. Rev. Mater. http://dx.doi.org/10.1038/natrevmats.2016.73 (2016).
Petersen, G. H., Alzghari, S. K., Chee, W., Sankari, S. S. & La-Beck, N. M. Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin. J. Control. Release 232, 255–264 (2016).
[No authors listed.] A billion dollar punt. Nat. Biotechnol. 24, 1453 (2006).
Carroll, J. Merck writes off RNAi, punts Sirna to Alnylam for $175M. FierceBiotech http://www.fiercebiotech.com/financials/merck-writes-off-rnai-punts-sirna-to-alnylam-for-175m (updated 4 Jul 2016).
Brunton, L. L., Chabner, B. & Knollmann, B. C. Goodman & Gilman's the Pharmacological Basis of Therapeutics (McGraw-Hill Medical, 2011).
Sykes, E. A. et al. Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proc. Natl Acad. Sci. USA 113, E1142–E1151 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Supplementary information S1–S3 (box, figure, table)
Supplementary information (PDF 302 kb)
PowerPoint slides
Rights and permissions
About this article
Cite this article
Wilhelm, S., Tavares, A. & Chan, W. Reply to “Evaluation of nanomedicines: stick to the basics”. Nat Rev Mater 1, 16074 (2016). https://doi.org/10.1038/natrevmats.2016.74
Published:
DOI: https://doi.org/10.1038/natrevmats.2016.74
This article is cited by
-
MMP-2 and upconverted UV dual-mediated drug sequential delivery and on-site immobilization for enhanced multidrug-resistant cancer therapy
Science China Chemistry (2023)
-
The dose threshold for nanoparticle tumour delivery
Nature Materials (2020)